Plus   Neg

Lonza Maintains 2019 Outlook

Lonza Group AG (LZAGF.PK), a supplier to the pharmaceutical, healthcare and life-science industries, said that it maintained its 2019 outlook based on the strong performance of its core healthcare businesses in Pharma Biotech & Nutrition, and taking into account the continued headwinds in its Specialty Ingredients portfolio.

For 2019, the company confirmed that mid-to-high-single digit sales growth, sustained high CORE EBITDA margin level.

Lonza adjusted its mid-term Guidance, following the disposal of its former Water Care business unit in February 2019, and to emphasize its strategic focus on growth in its core healthcare businesses.

The adjusted Mid-Term Guidance for Lonza's continuing operations, excluding the Water Care business unit, is confirmed. It still expects sales of 7.1 billion Swiss francs, CORE EBITDA margin of 30.5%.

Lonza said that the newly aligned segment Lonza Pharma Biotech & Nutrition performed strongly compared with the first-quarter of prior year and ahead of expectations. Lonza's newly aligned Specialty Ingredients segment faced challenges and the businesses performed below expectations with sales on the same level as in the first-quarter of 2018.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Morgan Stanley has cut its worst-case forecast on Tesla Inc.'s share price from the previous estimate of $97 to just $10, dealing another blow to the luxury electric car maker. The worst-case or "bear case" scenario by Morgan Stanley analysts takes into account the risk posed if Tesla misses its current sales outlook for China by about half. Snap Inc. on Monday announced the promotion of two executives as the company restructures its management team. The parent company of messaging app Snapchat said it has appointed Derek Andersen, currently its vice president of finance, as chief financial officer. The company also named interim CFO Lara Sweet as its first chief people officer. Both appointments are effective immediately. Nike Inc., Adidas AG and other footwear companies have urged U.S. President Donald Trump to reconsider his proposed tariffs on shoes imported from China, noting that any increase in the cost of importing shoes has a direct impact on the American footwear consumer. In a letter, more than 170 footwear companies have urged the President to immediately remove footwear from the proposed tariffs.
Follow RTT